ABEMACICLIB
| Brand name | VERZENIO |
|---|---|
| Active ingredient | ABEMACICLIB |
| Strength | 150MG |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | September 2017 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 7855211 | September 2031 | substance, product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.